Toward HIV eradication or remission: The tasks ahead

Science

Volumn 280, Issue 5371, 1998, Pages 1866-1867

  Ho, David D ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; OKT 3; SUPERANTIGEN; TUMOR NECROSIS FACTOR;

ERADICATION THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MEMORY; LATENT VIRUS INFECTION; PRIORITY JOURNAL; REMISSION; SHORT SURVEY; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS IMMUNITY; VIRUS REPLICATION;

ADJUVANTS, IMMUNOLOGIC; ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; REMISSION INDUCTION; VIRUS LATENCY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032546919     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.280.5371.1866     Document Type: Short Survey

References (24)

1. F. J. Palella et al., N. Engl. J. Med. 328, 853 (1998).
2. D. D. Ho et al., Nature 373, 123 (1995); X. Wei et al., ibid., p. 117.
3. D. D. Ho et al., Nature 373, 123 (1995); X. Wei et al., ibid., p. 117.
4. A. S. Perelson, A. U. Neumann, M. Markowitz, J. M. Leonard, D. D. Ho, Science 271, 1582 (1996).
5. A. S. Perelson et al., Nature 387, 188 (1997).
6. W. Cavert et al., Science 276, 960 (1997).
7. J. K. Wong et al., ibid. 278, 1291 (1997); D. Finzi et al., Ibid., p. 1295; T.-W. Chun et al., Proc. Natl. Acad. Sci. U.S.A. 94, 13193 (1997).
8. J. K. Wong et al., ibid. 278, 1291 (1997); D. Finzi et al., Ibid., p. 1295; T.-W. Chun et al., Proc. Natl. Acad. Sci. U.S.A. 94, 13193 (1997).
9. J. K. Wong et al., ibid. 278, 1291 (1997); D. Finzi et al., Ibid., p. 1295; T.-W. Chun et al., Proc. Natl. Acad. Sci. U.S.A. 94, 13193 (1997).
10. J. Cohen, Science 279, 1854 (1998).
11. Y. Cao, B. Ramratnam, D. D. Ho, unpublished results.
12. T.-W. Chun et al., Nature 387, 183 (1997).
13. A. R. McLean and C. A. Michie, Proc. Natl. Acad. Sci. U.S.A. 92, 3707 (1995); C. A. Michie et al., Nature 360, 264 (1992); D. F. Tough and J. Sprent, J. Exp. Med. 179, 1127 (1994); H. Mohri, S. Bonhoeffer, S. Monard, A. S. Perelson, D. D. Ho, Science 279, 1223 (1998).
14. A. R. McLean and C. A. Michie, Proc. Natl. Acad. Sci. U.S.A. 92, 3707 (1995); C. A. Michie et al., Nature 360, 264 (1992); D. F. Tough and J. Sprent, J. Exp. Med. 179, 1127 (1994); H. Mohri, S. Bonhoeffer, S. Monard, A. S. Perelson, D. D. Ho, Science 279, 1223 (1998).
15. A. R. McLean and C. A. Michie, Proc. Natl. Acad. Sci. U.S.A. 92, 3707 (1995); C. A. Michie et al., Nature 360, 264 (1992); D. F. Tough and J. Sprent, J. Exp. Med. 179, 1127 (1994); H. Mohri, S. Bonhoeffer, S. Monard, A. S. Perelson, D. D. Ho, Science 279, 1223 (1998).
16. A. R. McLean and C. A. Michie, Proc. Natl. Acad. Sci. U.S.A. 92, 3707 (1995); C. A. Michie et al., Nature 360, 264 (1992); D. F. Tough and J. Sprent, J. Exp. Med. 179, 1127 (1994); H. Mohri, S. Bonhoeffer, S. Monard, A. S. Perelson, D. D. Ho, Science 279, 1223 (1998).
17. M. Vesanen et al., paper presented at the International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, St. Petersburg, FL, 25-28 June 1997.
18. F. Raffi et al., Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, 1-5 February 1998, p. LB15; D. V. Havlir et al., ibid., p. LB16.
19. F. Raffi et al., Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, 1-5 February 1998, p. LB15; D. V. Havlir et al., ibid., p. LB16.
20. D. Unutmaz, P. Pileri, S. Abrignani, J. Exp. Med. 180, 1159 (1994).
21. A. S. Perelson and D. D. Ho, unpublished results.
22. L. Morris et al., J. Exp. Med., in press; G. S. Ogg et al., Science 279, 2103 (1998).
23. L. Morris et al., J. Exp. Med., in press; G. S. Ogg et al., Science 279, 2103 (1998).
24. I thank X. Jin, M. Markowitz, J. Moore, and A. Perelson for helpful comments and suggestions.